India-Indonesia Digital Push: UPI Integration to Enable Seamless Cross-Border Payments

New Delhi, July 7: India’s Unified Payments Interface (UPI) will be integrated with Indonesia’s payment system, marking a major milestone in digital financial cooperation between the two countries, Prime Minister Narendra Modi announced.

The integration will enable smoother cross-border transactions, offering greater convenience to individuals, businesses, and travellers by improving the speed and accessibility of digital payments between India and Indonesia.

The initiative highlights the growing global acceptance of India’s digital payment ecosystem and reflects the shared commitment of both nations to strengthen financial technology cooperation.

Officials said the collaboration will support innovation in the fintech sector, enhance economic connectivity, and create new opportunities for trade, tourism, and digital commerce.

The move is part of India’s ongoing efforts to expand international digital payment partnerships and promote secure, efficient, and inclusive financial solutions worldwide.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

  • Government, corporates and global foundations join hands on PRAGATI to empower 20,000 agri-entrepreneurs

    Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan recently launched PRAGATI, a nationwide initiative to build 20,000 agri-entrepreneurs and…

    Read More

  • Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia

    Milan, Italy, July 08 — Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), has today announced the publication of preclinical data supporting the potential of its liver-directed immune-shielded lentiviral gene therapy approach to treat methylmalonic acidemia (MMA), a severe inherited metabolic disorder. The findings, published in the Journal of Hepatology, show that a single systemic administration of a lentiviral vector encoding the MMUT gene led to sustained improvements in disease features in a validated mouse model of MMA, with effects lasting for the average lifespan of laboratory mice. Since the mice were treated when young, the study supports the durability of the gene therapy through postnatal growth and maturation of the liver. MMA is caused by a deficiency of methylmalonyl-CoA mutase, an enzyme that plays a critical role in the body’s metabolism of food. Its absence results in the accumulation of toxic metabolites that lead to recurrent metabolic crises, growth failure, neurological impairment, and multi-organ damage. In the study, researchers also treated mice with a dose containing an optimized MMUT transgene, thereby improving therapeutic efficacy. In the same mouse model of MMA, this…

    Read More

  • High-Energy Punjabi Party Anthem ‘Naachi Jaave’ Is Here

    Mumbai , July 8: The wait for this season’s ultimate party track is finally over. Tips Music has released its brand-new Punjabi single ‘Naachi Jaave‘,…

    Read More